A Two Period, Randomised, Open-label, Crossover Study to Assess the Adhesion of Buprenorphine Transdermal Delivery System 40 µg/h Patch and 20 µg/h Patch, in Healthy Volunteers
Phase of Trial: Phase I
Latest Information Update: 16 Feb 2016
At a glance
- Drugs Buprenorphine (Primary)
- Indications Pain
- Focus Therapeutic Use
- Sponsors Mundipharma Research
- 08 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jun 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 04 May 2015 New trial record